BUY Max Healthcare Institute Limited — Axis Securities
byAxis SecuritiesHorizon: NA (inferred 1 year)18 Aug 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
10 other SEBI-registered advisors have active long-term BUY calls on this stock, with 7 issued in the last 14 days
Advisor consensus · same horizon·17 Aug · yesterday
Max Healthcare Q1 results: Revenue, EBITDA rise 15% each; Margins at 24.8%
NewsCnbc-Tv18·13 Aug · 5d ago
Max Healthcare reported Q1 revenue of Rs. 2,982 Cr, a 16% YoY increase. Network Operating EBITDA grew 15% YoY to Rs. 704 Cr, and Q1 PAT was Rs. 357 Cr.
BSE · Company Update·13 Aug · 5d ago
Max Healthcare Profit Rises 34% To ₹1,442 Crore In FY26
NewsGoogle News·30 Jul · 3w ago
Max Healthcare Share: 2% உயர்வு! வளர்ச்சி அவுட்லுக் வலுவாக உள்ளதா?
NewsGoogle News·27 Jul · 3w ago
Max Healthcare Institute Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·13 Aug · 5d ago
Max Healthcare Institute Limited disclosed an update on ongoing litigation concerning its subsidiary, Kalinga Hospital Ltd. The National Company Law Tribunal (NCLT) permitted the opposing party to rec
NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·7 Aug · 1w ago
Max Healthcare Institute Limited disclosed an update on petitions filed before the National Company Law Tribunal concerning Kalinga Hospital Ltd. The matter has been adjourned to August 4, 2026.
NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·24 Jul · 4w ago
1 other SEBI-registered advisor has an active long-term SELL call on this stock, issued in the last 14 days
Advisor consensus · same horizon·14 Aug · 4d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Max Healthcare Institute
- SELL — Akshay Bhagwat, JM Financial13 Oct 2026 · ~3 months · target ₹700 · Active
- SELL — Prakash Gaba5 Oct 2026 · ~2 weeks · target ₹900 · Target hit
- BUY — Goldman Sachs1 Oct 2026 · ~1 year · target ₹1,200 · Active
- BUY — Emkay Global1 Oct 2026 · ~1 year · target ₹1,150 · Active
- SELL — Nagaraj Shetty, HDFC Securities30 Sept 2026 · ~3 months · target ₹870 · Target hit
More from Axis Securities
- BUY Eternal22 Oct 2026 · ~1 year · target ₹390 · Active
- BUY CREDITACCESS GRAMEEN22 Oct 2026 · ~1 year · target ₹1,405 · Active
- BUY CCL Products (India)19 Oct 2026 · ~1 year · target ₹1,255 · Active
- BUY Federal Bank19 Oct 2026 · ~1 year · target ₹405 · Active
- BUY LTM19 Oct 2026 · ~1 year · target ₹4,960 · Active

